EP1406699 - ANTITUMORAL FORMULATIONS OF THIOXANTHENONE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2006 Database last updated on 19.10.2024 | Most recent event Tooltip | 06.01.2006 | Application deemed to be withdrawn | published on 22.02.2006 [2006/08] | Applicant(s) | For all designated states Sanofi-Aventis 174, Avenue de France 75013 Paris / FR | [2004/44] |
Former [2004/16] | For all designated states SANOFI-SYNTHELABO 174, Avenue de France 75013 Paris / FR | Inventor(s) | 01 /
BLUNDELL, Ross 85 Roseberry Crescent Jesmond, Newcastle Upon Tyne NE2 1EX / GB | 02 /
BAKER, Edward 3 Bradshawgate, North Farm, Swinhoe Chathill, Northumberland NE67 5AA / GB | [2004/16] | Representative(s) | Varady, Peter Sanofi-Aventis 174 avenue de France 75013 Paris / FR | [N/P] |
Former [2004/16] | Varady, Peter Sanofi-Synthelabo Direction Juridique Centrale Departement Brevets 174, avenue de France 75635 Paris Cedex 13 / FR | Application number, filing date | 02748985.5 | 28.06.2002 | [2004/16] | WO2002GB03012 | Priority number, date | GB20010015893 | 28.06.2001 Original published format: GB 0115893 | [2004/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03002202 | Date: | 09.01.2003 | Language: | EN | [2003/02] | Type: | A1 Application with search report | No.: | EP1406699 | Date: | 14.04.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.01.2003 takes the place of the publication of the European patent application. | [2004/16] | Search report(s) | International search report - published on: | EP | 09.01.2003 | Classification | IPC: | A61P35/00, A61K9/08, A61K31/38 | [2004/16] | CPC: |
A61K9/0019 (EP,US);
A61K31/382 (EP,KR,US);
A61P35/00 (EP);
A61K47/02 (EP,US);
A61K47/12 (EP,US);
A61K47/26 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/16] | Extension states | AL | 28.01.2004 | LT | 28.01.2004 | LV | 28.01.2004 | MK | 28.01.2004 | RO | 28.01.2004 | SI | 28.01.2004 | Title | German: | ANTITUMORALE ZUSAMMENZETZUNGEN ENTHALTENDE THIOXANTHENONE | [2004/16] | English: | ANTITUMORAL FORMULATIONS OF THIOXANTHENONE | [2004/16] | French: | FORMULATIONS DE THIOXANTHENONE ANTI-TUMORALES | [2004/16] | Entry into regional phase | 28.01.2004 | National basic fee paid | 28.01.2004 | Designation fee(s) paid | 28.01.2004 | Examination fee paid | Examination procedure | 07.01.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.01.2004 | Examination requested [2004/16] | 27.05.2004 | Despatch of a communication from the examining division (Time limit: M04) | 17.09.2004 | Reply to a communication from the examining division | 29.03.2005 | Despatch of a communication from the examining division (Time limit: M04) | 09.08.2005 | Application deemed to be withdrawn, date of legal effect [2006/08] | 12.09.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/08] | Fees paid | Renewal fee | 14.06.2004 | Renewal fee patent year 03 | 14.06.2005 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US5665760 (BROWN STEPHEN [GB], et al) [XY] 1,2,4-6,18-20 * column 3, lines 1-67 * * column 29, lines 1-49; example 31A; table 9 * * column 30, line 40 - column 32, line 10; tables 10,14 *; | [DY]EP0882723 (SANOFI SA [FR]) [DY] 1,2,4-6,18-20* page 5, lines 13-53; example 31A; claim - *; | [X] - IZBICKA, E. ET AL., "Effects of SW33377, SW 68210 and SW 71425 thioxanthones on in vitro colony formation of freshly explanted human tumor cells", INVESTIGATIONAL NEW DRUGS, (1999), vol. 16, no. 3, page 221-225, XP009000983 [X] 18-20 * the whole document * DOI: http://dx.doi.org/10.1023/A:1006152100299 |